While celebrities may live a life full of glamor and fame, that doesn't mean they don't deal with health issues like the rest ...

Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.

He underwent a cadaver renal transplant (111 mis-match) in July 2002 and received tacrolimus and prednisolone. The kidney functioned ... or family history of neurological disease.

"Due to the development of the state's health system, it is currently possible to perform various complex surgeries, including neuro surgeries, in the state. In addition, after the introduction of ...

Peripheral neuropathy is an uncommon neurological side effect of tacrolimus and has rarely been reported in renal transplantation. We report a patient who received a living-related donor kidney ...

Søren Tulstrup, President and CEO, Hansa Biopharma said, 2024 proved to be a transformative year for Hansa, marked by ongoing commercial success of IDEFIRIX® across Europe and the achievement of key ...

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...

A 2009 study estimated that 52% of kidney transplant candidates who were at least 60 years ... severe peripheral vascular disease, severe neurological disease, chronic pulmonary disease, and ...

eGenesis isn’t the only company developing pig organs for human transplant. In February, the FDA approved the first large ...

There is no standard approach to starting kidney transplant evaluations in patients referred from dialysis facilities to ...